Charles River Laboratories (CRL) Stock: Revenue, Earnings, Margins & Valuation
Charles River Laboratories share price
| Price (USD) | 359.41 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 17.16 USD bn |
Annual and quarterly filings: SEC EDGAR – Charles River Laboratories
Charles River Laboratories (CRL), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report, visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Charles River Laboratories business model
The income statement of Charles River Laboratories is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
Sector: Health Care
More stock analyses like Charles River Laboratories
- Cigna stock (CI)
- Cooper Companies (The) stock (COO)
- CVS Health stock (CVS)
- Danaher Corporation stock (DHR)
- Charles Schwab Corp. stock (SCHW)
- CF Industries stock (CF)
- Charter Communications stock (CHTR)
- CenterPoint Energy stock (CNP)